Abstract
BackgroundBlocking the PD-1/PD-L1 pathway with antibodies has been effective in treating multiple types of cancers. However, orally administered small molecules can allow for better tumor penetrance and more convenient dosing...
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have